Skeletal muscle regeneration declines with age despite the persistence of satellite cells, indicating that regenerative impairment reflects functional dysregulation rather than stem cell loss. Increasing evidence identifies early satellite cell activation as a stress-sensitive, rate-limiting checkpoint that is preferentially disrupted in aged muscle. Integrative analyses indicate that aged satellite cells exhibit elevated stress programs and reduced membrane remodeling capacity, accompanied by weakened activa-tion-associated transcriptional signatures, while proliferative and differentiation pro-grams remain relatively accessible in successfully activated cells. This imbalance is consistent with impaired activation fidelity, in which early instability drives compen-satory downstream responses at the expense of long-term self-renewal. Within this framework, MG53 (TRIM72) is positioned beyond its canonical role in myofiber mem-brane repair as a permissive, stress-responsive regulator that stabilizes the early acti-vation environment. Rather than directly specifying cell fate, MG53 is proposed to support early activation by limiting stress-associated membrane disruption and main-taining coordination of the activation program under age-related constraints. These ob-servations suggest that restoring activation quality, rather than amplifying proliferation, may represent a more durable strategy to preserve regenerative capacity in aging skeletal muscle.

Skeletal muscle regeneration declines with age despite the persistence of satellite cells (muscle stem cells, MuSCs), suggesting that regenerative impairment reflects functional dysregulation rather than MuSC depletion. Increasing evidence identifies early MuSC activation during the immediate post-injury period as a stress-sensitive, rate-limiting transition that is particularly vulnerable in aged muscle. Aged MuSCs exhibit elevated stress responses and reduced membrane remodeling capacity, accompanied by weakened activation-associated transcriptional induction. In contrast, proliferative and differentiation programs remain largely intact once activation is successfully initiated. These findings underscore that impaired coordination during early activation contributes to long-term regenerative decline in aging. Within this framework, MG53 (tripartite motif–containing protein 72, TRIM72), a muscle-enriched TRIM family E3 ubiquitin ligase originally identified as a mediator of sarcolemmal membrane repair, may also function as a stress-responsive regulator that stabilizes the early activation environment. Rather than directly determining cell fate, MG53 is proposed to facilitate activation by mitigating stress-associated membrane disruption and maintaining programmatic coordination under age-related physiological constraints. Most mechanistic evidence derives from rodent models, and direct validation in human aging muscle remains limited. These observations suggest that targeting early activation, rather than simply increasing proliferation, may better preserve regenerative capacity in aging skeletal muscle.

Background: Immunosuppressed patients are at an increased risk for developing odontogenic and orofacial infections, which can present with atypical processes and features that may mimic rare but life-threatening infections such as Ludwig’s angina. Differentiating cellulitis from a deep neck space infection is often challenging in this population in acute settings due to a broad differential diagnosis and blunted inflammatory responses. This diagnostic uncertainty complicates acute risk stratification and may delay recognition of conditions requiring early airway evaluation and intervention. Case Presentation: We present the case of a 28-year-old male with chronic myelogenous leukemia on immunosuppression with dasatinib who developed unilateral facial swelling and severe odontogenic pain that was refractory to empiric antibiotic therapy. The patient’s presentation with rapid clinical progression, early trismus, submandibular involvement, and floor-of-mouth tenderness raised significant concern for evolving Ludwig’s angina. Laboratory evaluation demonstrated elevated inflammatory markers, including erythrocyte sedimentation rate and C-reactive protein, further complicating early assessment. Imaging was promptly obtained to determine the nature of the infection, and the patient was admitted for intravenous antibiotic therapy and airway monitoring. Clinical improvement ensued. Conclusions: This case highlights the diagnostic overlap between facial cellulitis and Ludwig’s angina and underscores the importance of prompt imaging, airway monitoring, and clinical vigilance for risk stratification of immunocompromised patients in the acute setting to prevent life-threatening complications.

Traditional opiate immunoassays do not reliably detect fentanyl, and patterns of presumptive drug co-positivity in psychiatric emergency care remain poorly characterized. To describe class-specific urine drug screen positivity, quantify co-positivity among explicitly co-tested encounters, and assess the fentanyl testing gap among adult psychiatric emergency department encounters at two hospitals in West Virginia. We retrospectively analyzed 1,091 adult psychiatric emergency department encounters at two West Virginia hospitals from October 2020 through December 2024. Testing was clinician-directed. Class-specific estimates used only encounters tested for each class. Six-core-class co-positivity was assessed among 281 complete-panel encounters; complete and incomplete panels were compared. Multivariable logistic regression evaluated fentanyl and amphetamine/methamphetamine co-positivity among 350 co-tested encounters. Among tested encounters, tetrahydrocannabinol was positive in 214 of 513 (41.7%), amphetamine/methamphetamine in 203 of 509 (39.9%), and fentanyl in 146 of 519 (28.1%). Among complete-panel encounters, 128 of 281 (45.6%) were positive for at least two core classes. Substance-related chief complaints were more common among complete-panel encounters than among incomplete-panel encounters (73.3% versus 56.8%; p < .001). Among fentanyl-positive encounters co-tested for amphetamine/methamphetamine, 81 of 108 (75.0%) were also positive for amphetamine/methamphetamine. Amphetamine/methamphetamine positivity was associated with fentanyl positivity (adjusted odds ratio, 8.5; 95% confidence interval, 4.8-14.9). Among 118 fentanyl-positive encounters co-tested using the traditional opiate assay, 91 (77.1%) were opiate-screen-negative. Fentanyl and amphetamine/methamphetamine screens frequently overlapped in clinically selected subsets, and traditional opiate screening missed most fentanyl-positive screens. Psychiatric emergency services in fentanyl-affected regions should evaluate fentanyl-specific testing. Because immunoassays were presumptive and testing was nonprotocolized, findings represent screening yield, not confirmed exposure or population prevalence.